Skip to content

News

ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse

ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse

Research presented at the American Society of Clinical Oncology annual meeting this week suggests that adding the drug pazopanib (trade name Votrient) to standard treatment extends progression-free survival in ovarian … Continued

Update on Treatment for Recurrent Ovarian Cancer

Update on Treatment for Recurrent Ovarian Cancer

A new article summarizes treatment options for women with recurrent ovarian cancer. The article includes information about when to treat a recurrence, what agents are available and the goals of … Continued

Many Ovarian Cancer Patients Use Humor to Cope

Many Ovarian Cancer Patients Use Humor to Cope

Researchers at the University of Wisconsin, including former OCRF grantee Stephen Rose, MD, conducted a qualitative research study looking at how patients with recurrent ovarian cancer experience humor to gain … Continued

Endometriosis Treatments Lower Ovarian Cancer Risk

Endometriosis Treatments Lower Ovarian Cancer Risk

Women who had surgery to treat their endometriosis also lowered their risk of developing ovarian cancer. A study of approximately 600 Swedish women found that those who either had one … Continued

Disparities in Ovarian Cancer Care and Quality

Disparities in Ovarian Cancer Care and Quality

In a new study of over 47,000 women with ovarian cancer, researchers found disparities in the quality of ovarian cancer care and survival according to race and socioeconomic status. Not … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.